FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285405524> ?p ?o ?g. }

• W4285405524 endingPage "40" @default.
• W4285405524 startingPage "34" @default.
• W4285405524 abstract "BackgroundLeukotrienes are pro-inflammatory vasoactive lipid mediators implicated in the pathophysiology of atherosclerotic cardiovascular disease. We studied the effect of the 5-lipoxygenase-activating protein inhibitor AZD5718 on leukotriene biosynthesis and coronary microvascular function in a single-blind, phase 2a study.MethodsPatients 7–28 days after myocardial infarction (±ST elevation), with <50% left anterior descending coronary artery stenosis and Thrombolysis in Myocardial Infarction flow grade ≥ 2 after percutaneous coronary intervention, were randomized 2:1:2 to once-daily AZD5718 200 mg or 50 mg, or placebo, in 4- and 12-week cohorts. Change in urine leukotriene E4 (uLTE4) was the primary endpoint, and coronary flow velocity reserve (CFVR; via echocardiography) was the key secondary endpoint.ResultsOf 129 randomized patients, 128 received treatment (200 mg, n = 52; 50 mg, n = 25; placebo, n = 51). Statistically significant reductions in uLTE4 levels of >80% were observed in both AZD5718 groups versus the placebo group at 4 and 12 weeks. No significant changes in CFVR were observed for AZD5718 versus placebo. Adverse events (AEs) occurred in 12/18, 3/6 and 6/13 patients receiving 200 mg, 50 mg and placebo, respectively, in the 4-week cohort, and in 27/34, 14/19 and 24/38 patients, respectively, in the 12-week cohort. Serious AEs in seven patients receiving AZD5718 and four receiving placebo were not treatment-related, and there were no deaths.ConclusionsIn patients with recent myocardial infarction, AZD5718 was well tolerated, and leukotriene biosynthesis was dose-dependently inhibited. No significant changes in CFVR were detected. ClinicalTrials.gov identifier: NCT03317002." @default.
• W4285405524 created "2022-07-14" @default.
• W4285405524 creator A5008945972 @default.
• W4285405524 creator A5013553039 @default.
• W4285405524 creator A5026153766 @default.
• W4285405524 creator A5026529813 @default.
• W4285405524 creator A5029540294 @default.
• W4285405524 creator A5039027696 @default.
• W4285405524 creator A5050380848 @default.
• W4285405524 creator A5058239509 @default.
• W4285405524 creator A5062282863 @default.
• W4285405524 creator A5063635241 @default.
• W4285405524 creator A5065907810 @default.
• W4285405524 creator A5068373500 @default.
• W4285405524 creator A5069475935 @default.
• W4285405524 creator A5077055608 @default.
• W4285405524 creator A5077650130 @default.
• W4285405524 creator A5078991342 @default.
• W4285405524 date "2022-10-01" @default.
• W4285405524 modified "2023-09-30" @default.
• W4285405524 title "Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study" @default.
• W4285405524 cites W1997307265 @default.
• W4285405524 cites W2009422790 @default.
• W4285405524 cites W2032255457 @default.
• W4285405524 cites W2035093916 @default.
• W4285405524 cites W2083596061 @default.
• W4285405524 cites W2129942624 @default.
• W4285405524 cites W2145189353 @default.
• W4285405524 cites W2151223394 @default.
• W4285405524 cites W2157185884 @default.
• W4285405524 cites W2160138934 @default.
• W4285405524 cites W2163829863 @default.
• W4285405524 cites W2168630917 @default.
• W4285405524 cites W2626246102 @default.
• W4285405524 cites W2789248771 @default.
• W4285405524 cites W2791101683 @default.
• W4285405524 cites W2804409796 @default.
• W4285405524 cites W2914637605 @default.
• W4285405524 cites W2932085132 @default.
• W4285405524 cites W2991896232 @default.
• W4285405524 cites W3045904014 @default.
• W4285405524 cites W3107670427 @default.
• W4285405524 cites W3196664545 @default.
• W4285405524 doi "https://doi.org/10.1016/j.ijcard.2022.07.016" @default.
• W4285405524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35842004" @default.
• W4285405524 hasPublicationYear "2022" @default.
• W4285405524 type Work @default.
• W4285405524 citedByCount "3" @default.
• W4285405524 countsByYear W42854055242023 @default.
• W4285405524 crossrefType "journal-article" @default.
• W4285405524 hasAuthorship W4285405524A5008945972 @default.
• W4285405524 hasAuthorship W4285405524A5013553039 @default.
• W4285405524 hasAuthorship W4285405524A5026153766 @default.
• W4285405524 hasAuthorship W4285405524A5026529813 @default.
• W4285405524 hasAuthorship W4285405524A5029540294 @default.
• W4285405524 hasAuthorship W4285405524A5039027696 @default.
• W4285405524 hasAuthorship W4285405524A5050380848 @default.
• W4285405524 hasAuthorship W4285405524A5058239509 @default.
• W4285405524 hasAuthorship W4285405524A5062282863 @default.
• W4285405524 hasAuthorship W4285405524A5063635241 @default.
• W4285405524 hasAuthorship W4285405524A5065907810 @default.
• W4285405524 hasAuthorship W4285405524A5068373500 @default.
• W4285405524 hasAuthorship W4285405524A5069475935 @default.
• W4285405524 hasAuthorship W4285405524A5077055608 @default.
• W4285405524 hasAuthorship W4285405524A5077650130 @default.
• W4285405524 hasAuthorship W4285405524A5078991342 @default.
• W4285405524 hasBestOaLocation W42854055241 @default.
• W4285405524 hasConcept C126322002 @default.
• W4285405524 hasConcept C142724271 @default.
• W4285405524 hasConcept C164705383 @default.
• W4285405524 hasConcept C168563851 @default.
• W4285405524 hasConcept C197934379 @default.
• W4285405524 hasConcept C203092338 @default.
• W4285405524 hasConcept C204787440 @default.
• W4285405524 hasConcept C27081682 @default.
• W4285405524 hasConcept C2777995511 @default.
• W4285405524 hasConcept C2780400711 @default.
• W4285405524 hasConcept C500558357 @default.
• W4285405524 hasConcept C71924100 @default.
• W4285405524 hasConcept C72563966 @default.
• W4285405524 hasConcept C90924648 @default.
• W4285405524 hasConceptScore W4285405524C126322002 @default.
• W4285405524 hasConceptScore W4285405524C142724271 @default.
• W4285405524 hasConceptScore W4285405524C164705383 @default.
• W4285405524 hasConceptScore W4285405524C168563851 @default.
• W4285405524 hasConceptScore W4285405524C197934379 @default.
• W4285405524 hasConceptScore W4285405524C203092338 @default.
• W4285405524 hasConceptScore W4285405524C204787440 @default.
• W4285405524 hasConceptScore W4285405524C27081682 @default.
• W4285405524 hasConceptScore W4285405524C2777995511 @default.
• W4285405524 hasConceptScore W4285405524C2780400711 @default.
• W4285405524 hasConceptScore W4285405524C500558357 @default.
• W4285405524 hasConceptScore W4285405524C71924100 @default.
• W4285405524 hasConceptScore W4285405524C72563966 @default.
• W4285405524 hasConceptScore W4285405524C90924648 @default.
• W4285405524 hasLocation W42854055241 @default.
• W4285405524 hasLocation W42854055242 @default.
• W4285405524 hasLocation W42854055243 @default.

• next